TGTX - TG Therapeutics Inc
IEX Last Trade
23.47
-0.040 -0.170%
Share volume: 2,936,370
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$23.51
-0.04
-0.17%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-09 | 2023-03-01 | 2023-05-08 | 2023-08-04 | 2023-11-06 | 2024-02-29 | 2024-05-06 | |
| Total revenue | 594.000 K | 94.000 K | 81.000 K | 7.803 M | 16.074 M | 165.815 M | 43.970 M | 63.474 M | |
| Cost of revenue | 23.000 K | 2.000 K | 3.000 K | 857.000 K | 1.911 M | 3.509 M | 7.854 M | 5.441 M | |
| Gross profit | 571.000 K | 92.000 K | 78.000 K | 6.946 M | 14.163 M | 162.306 M | 36.116 M | 58.033 M | |
| -83.89% | -15.22% | 8,805.13% | 103.90% | 1,045.99% | -77.75% | 60.69% | |||
| Operating expenses | 40.488 M | 28.066 M | 41.090 M | 37.114 M | 46.296 M | 38.338 M | 39.217 M | 57.964 M | |
| Selling general and admin | 15.942 M | 10.514 M | 17.207 M | 22.828 M | 23.838 M | 26.500 M | 24.617 M | 27.694 M | |
| Research and development | 24.546 M | 17.552 M | 23.883 M | 14.286 M | 22.458 M | 11.838 M | 14.600 M | 30.270 M | |
| Total expenses | 39.535 M | 35.057 M | 52.144 M | 44.795 M | 60.748 M | 51.031 M | 56.455 M | 72.744 M | |
| -11.33% | 48.74% | -14.09% | 35.61% | -16.00% | 10.63% | 28.85% | |||
| Operating income | -38.941 M | -34.963 M | -52.063 M | -36.992 M | -44.674 M | 114.784 M | -12.485 M | -9.270 M | |
| Ebit | -38.941 M | -34.963 M | -52.063 M | -36.992 M | -44.674 M | 114.784 M | -12.485 M | -9.270 M | |
| Pretax income | -40.510 M | -35.818 M | -52.994 M | -39.232 M | -47.610 M | 113.930 M | -14.026 M | -10.678 M | |
| -11.58% | 47.95% | -25.97% | 21.36% | -339.30% | -112.31% | -23.87% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 29.000 K | |
| Net income basic | -40.510 M | -35.818 M | -52.994 M | -39.232 M | -47.610 M | 113.930 M | -14.026 M | -10.707 M | |
| 11.58% | -47.95% | 25.97% | -21.36% | 339.30% | -112.31% | 23.66% | |||
| Net income | -40.510 M | -35.818 M | -52.994 M | -39.232 M | -47.610 M | 113.930 M | -14.026 M | -10.707 M | |
| 11.58% | -47.95% | 25.97% | -21.36% | 339.30% | -112.31% | 23.66% |